Rosuvastatin inhibits TGF-β1 expression and alleviates myocardial fibrosis in diabetic rats

Pharmazie

Volumn 68, Issue 5, 2013, Pages 355-358

  Ma, Yu Xiao ^a   Li, Wei Hua ^a   Xie, Qiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; COLLAGEN; CREATINE KINASE ISOENZYME; HEMOGLOBIN A1C; ROSUVASTATIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; BODY WEIGHT; CARDIOMYOPATHIES; COLLAGEN; CREATINE KINASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FIBROSIS; FLUOROBENZENES; HEMOGLOBIN A, GLYCOSYLATED; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTROPHY, LEFT VENTRICULAR; MALE; NATRIURETIC PEPTIDE, BRAIN; PYRIMIDINES; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84878381675     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2745     Document Type: Article

References (11)

1. Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74: 184-195. (Pubitemid 46517504)
2. Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25: 543-567. (Pubitemid 39096070)
3. Gu WL, Chen CX, Wu Q, Lü J, Liu Y, Zhang SJ (2010) Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling. Pharmazie 65: 770-775.
4. Guo P, Wu C, Masaki T, Mori H, Nishiyama A(2011) Subdose of fasudil suppresses myocardial fibrosis in aldosterone-salt-treated uninephrectomized rats. Pharmazie 66: 716-719.
5. Ichiki T, Takeda K, Tokunou T, Iino N, Egashira K, Shimokawa H, Hirano K, Kanaide H, Takeshita A (2001) Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzymeAreductase inhibitors in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 1896-1901. (Pubitemid 34219738)
6. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653. (Pubitemid 41817713)
7. Planavila A, Laguna JC, Vazquez-Carrera M (2005) Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta 1687: 76-83. (Pubitemid 40228987)
8. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602.
9. van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ (2004) Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61: 218-226. (Pubitemid 38091762)
10. Vincze Z, Brugos B (2012) Influence of statin treatment on mortality of patients with myocardial infarction. Pharmazie 67: 419-421.
11. Zhao H, Liao Y, Minamino T, Asano Y, Asakura M, Kim J, Asanuma H, Takashima S, Hori M, Kitakaze M(2008) Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress. Hypertens Res 31: 1977-1987.